SciELO - Scientific Electronic Library Online

vol.23Low performance of operational indicators for leprosy control in the state of Bahia: spatiotemporal patterns, 2001-2014 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Revista Brasileira de Epidemiologia

Print version ISSN 1415-790XOn-line version ISSN 1980-5497

Rev. bras. epidemiol. vol.23  Rio de Janeiro  2020  Epub Mar 09, 2020 


Timely care linkage of people living with HIV in a reference health service, Belo Horizonte, Minas Gerais

Romara Elizeu Amaro PerdigãoI

Palmira de Fátima BonoloI

Micheline Rosa SilveiraI

Dirce Inês da SilvaI  II

Maria das Graças Braga CeccatoI

IUniversidade Federal de Minas Gerais - Belo Horizonte (MG), Brasil.

IIFundação Hospitalar de Minas Gerais/Hospital Eduardo de Menezes - Belo Horizonte (MG), Brasil.



Linkage is a critical step in the ongoing care of human immunodeficiency virus (HIV/aids) infection and is essential for providing access to antiretroviral therapy, as well as comprehensive care.


Cross-sectional study on people living with HIV (PLHIV), aged ≥ 18 years old, linked between January and December 2015, in a referral service for outpatient and hospital care specialized in HIV/AIDS in Belo Horizonte, Minas Gerais. Linkage time was defined as the time from diagnosis to service linkage. Timely care linkage was considered when this time was ≤ 90 days. Data were collected through clinical records. A logistic regression analysis with a confidence interval of 95% (95%CI) was performed.


Among 208 patients, most of them were males (77.8%) with a mean age of 39 years. About 45% presented AIDS-defining conditions at the moment of linkage. Linkage time presented a mean of 138 ± 397 days. And timely linkage occurred for 76.9% of the patients. The variables associated with timely care linkage were: age ≥ 48 years (odds ratio - OR = 8.50; 95%CI 1.53 - 47.28), currently working (OR = 3.69; 95%CI 1.33 - 10.25) at the time of linkage, and present CD4+ T lymphocyte count (CD4+ T) ≤ 200 cells/mm3 at the time of HIV diagnosis (OR = 4.84; 95%CI 1.54 - 15.18). There was an important proportion of timely care linkage among PLHIV, but with late diagnosis.


Interventions should be targeted at younger people with higher CD4+ T lymphocyte counts, in order to better provide continuous HIV care.

Keywords: HIV; AIDS; Continuity of Patient Care



A vinculação é um passo fundamental para o cuidado contínuo da infecção pelo vírus da imunodeficiência humana (HIV/aids), sendo essencial para proporcionar o acesso à terapia antirretroviral, bem como ao cuidado integral.


Estudo transversal, com pessoas vivendo com HIV (PVHIV), idade ≥ 18 anos, vinculadas entre janeiro e dezembro de 2015, em um serviço de referência para assistência ambulatorial e hospitalar especializada em HIV/aids em Belo Horizonte (MG). O tempo de vinculação foi definido como o tempo do diagnóstico até a vinculação ao serviço. Considerou-se vinculação oportuna quando esse tempo foi menor ou igual a 90 dias. Os dados foram coletados por meio de prontuários clínicos. Realizou-se análise de regressão logística com intervalo de confiança de 95% (IC95%).


Entre os 208 pacientes, a maioria era do sexo masculino (77,8%) com idade média de 39 anos. Cerca de 45% apresentaram condições definidoras de aids na vinculação. O tempo de vinculação apresentou média de 138 ± 397 dias, e a vinculação oportuna ocorreu para 76,9% dos pacientes. As variáveis associadas com a vinculação oportuna foram: ter idade ≥ 48 anos (odds ratio - OR = 8,50; IC95% 1,53 - 47,28), estar trabalhando (OR = 3,69; IC95% 1,33 - 10,25) no momento da vinculação e apresentar contagem de linfócitos T CD4 (LT CD4+) ≤ 200 células/mm3 no momento do diagnóstico de HIV (OR = 4,84; IC95% 1,54 - 15,18). Observou-se proporção importante de vinculação oportuna entre as PVHA, porém com diagnóstico tardio.


Intervenções devem ser direcionadas para pessoas mais jovens e com maior contagem de LT CD4+, visando uma melhor prestação de cuidados contínuos em HIV.

Palavras-chave: HIV; Aids; Continuidade da Assistência ao Paciente


The spread of the human immunodeficiency virus (HIV) epidemic in heterogeneous populations in Brazil and around the world has paralleled technological advances achieved as treatment, including high-potency antiretroviral drugs, increased availability and accessibility1 to health services, testing laboratory tests for early diagnosis and follow-up of HIV infection treatment. This has resulted in improved access to antiretroviral therapy (ART), inherent in the supply and continued availability, including treatment for opportunistic co-infections2,3.

In addition, there are updates to the World Health Organization (WHO) recommendations to start treatment more timely, regardless of CD4 T lymphocyte count (CD4+ T) and viral load (VL) of people living with HIV (PLHIV)2,3. These advances have resulted in a significant drop in mortality, a reduction in opportunistic infections, and a decrease in the likelihood of HIV transmission. In addition, studies also portray improvement in the quality of life of PLHIV4,5.

Despite these advances, many individuals are still beginning treatment care for HIV infection with a CD4+ T count below 200 cells/mm3, or with an AIDS-defining event. This more advanced or untimely initiation of care is generally associated with poor immune recovery6,7 and shorter survival8, in addition to higher direct health costs and social losses9, as well as increased risk of HIV transmission10.

Thus, timely detection of HIV infection is desirable for all populations. The earlier the infection is diagnosed and the faster you are linked to a specialized referral service for follow-up treatment, the better the prognosis of the disease and the lower the chance of virus transmission. The quality of health care for the treatment of HIV infection requires individuals to perform diagnostic tests, to be linked to the service, to remain in care, to start ART, and to achieve viral load suppression11,12. This dynamic is known as the care cascade, and its understanding is essential for controlling HIV transmission9,10.

Linkage is defined as the first consultation with a prescribing authority in a referral care service after the diagnosis of HIV13,14. It is the second step in the cascade of continuous care after diagnosis and is essential for assessing patient health and providing access to ART15 as well as prevention interventions12.

Clinically, timely care linkage to HIV is associated with improved health and quality of life, as patients benefit from ART, as well as immunizations, screening, and prophylaxis for opportunistic infections and other sexually transmitted diseases16,17. Thus, the objective of this study was to analyze the linkage and the factors associated with it in patients treated at a specialized HIV service of the public health system of Minas Gerais.


Analytical, cross-sectional study conducted in PLHIV who were linked to a specialized outpatient service (SOS) in HIV of a hospital belonging to the public health network of Minas Gerais. This service has regional and state strategic importance, at secondary and tertiary levels of complexity, being the hospital reference of Belo Horizonte (Minas Gerais), of importance in the care network for PLHIV. For this study, it was considered that the successful treatment of HIV infection has required processes from the initial diagnosis to clinical outcomes.

Patients treated at the first consultation at the SOS of the referred hospital, from January to December 2015, aged 18 years old or older and diagnosed with HIV infection were included. For linkage analysis, women who were pregnant or who became pregnant throughout the project, individuals who had previously received outpatient care in another SOS and those who were under home care were excluded.

Data collection was performed using a standardized printed form based on instruments developed and published mainly by Guimarães et al.18 and Mugavero et al.13. An investigation was carried out in the clinical records (both physical and electronic ones) and also in the Logistic Control System of Medicines and in the CD4/CD8 and VL Laboratory Examination Control System of the Ministry of Health.

The forms were typed into the EpiInfo® 3.5.4 software. The quality of data collection and typing was double verified in 10% of the sample by a second researcher. The agreement between examiners was assessed by Kappa statistics (k = 0.92), indicating perfect agreement in both cases19.

The measure of linkage (dependent variable) was constructed using clinical records. Linkage was defined as the first consultation with a care provider in the SOS after the diagnosis of HIV20,21. Linkage time was determined as the period from diagnosis to service linkage, measured by the difference between the date of the first examination of the HIV diagnosis and the date of the first consultation13,22. For analysis purposes, this time was dichotomized and was considered timely when it was under or equal to 90 days13,14.

Independent variables were classified into three groups:

  • sociodemographic: age in percentiles (19-30 years, 31-47 years and ≥ 48 years), gender (male, female), skin color (white, black and brown), education level (> 8 years and ≤ 8 years), marital status (married/stable union, single, widowed, divorced/separated), children (yes or no), place of residence (Belo Horizonte or other municipality), work (yes or no);

  • lifestyle habits: current or past use of alcohol, tobacco, cocaine, crack and other drugs (yes or no);

  • clinic: VL at diagnosis, immune condition (CD4+ T) at diagnosis and at first visit, clinical condition, comorbidities, coinfection, and psychiatric diagnosis at first visit.

In order to obtain clinical data on CD4+ T and plasma VL counts in the diagnosis, the exams performed on the same date as the diagnosis of HIV infection or up to seven days after the initiation of ART22 were taken into account. For clinical data for the first visit, test results (CD4+ T and plasma VL) were observed within three months before or after the first visit. The patient’s clinical condition was considered according to the classification for HIV23 diseases (categories A, B and C) at the first outpatient visit. The comorbidities were those reported at the first visit (immunological diseases, cancers and metabolic diseases - and diabetes, hypertension, dyslipidemia, hypertriglyceridemia, hypothyroidism). Coinfections were the infectious diseases recorded at the first visit or in the discharge summary of hospitalized patients. The psychiatric diagnosis was also obtained by recording the first consultation.

Descriptive analysis of the variables was performed, with frequency distribution tables and their respective 95% confidence intervals (CI). Pearson’s χ2 test was used to compare the proportions of categorical variables between groups, adopting a significance level of 5%. The measure of association was obtained by odds ratio (OR). To evaluate the association between timely care linkage and independent variables, multiple logistic regression was performed. Variables with p ≤ 0.20 or of clinical and/or epidemiological importance were included in the multiple logistic model, remaining those with p <0.05. The Hosmer-Lemeshow test was employed to verify the adequacy of the final model. Data were analyzed using the Statistical Package for Social Sciences software, version 22.

This study is part of the Antiretroviral Therapy Effectiveness in Coinfected Subjects (Efetividade em Coinfectados da Terapia Antirretroviral - ECOART) project in people living with human immunodeficiency virus (HIV)/AIDS, HIV/tuberculosis, HIV/leprosy and HIV/visceral leishmaniasis in Belo Horizonte, with the approval of the Research Ethics (COEP) of the Federal University of Minas Gerais, under Certificate of Presentation for Ethical Appreciation (CAAE) number 31192914.3.0000.5149, and the Eduardo de Menezes Hospital of the Minas Gerais State Hospital Foundation (FHEMIG), under CAAE Number 31192914.3.3001.5124.


Between January and December 2015, 208 PLHIV were outpatient-linked at the assessed health service. Among the sociodemographic characteristics, most of them were males (77.9%), with mean age ± standard deviation (SD) = 39.3 ± 11.9 and median of 38 years. There was a higher proportion (40.1%) of the level of education equivalent to complete high school. Regarding marital status, the number of single, widowed and separated was almost three times higher than those who lived with a spouse or partner. The percentage of people with autonomous occupational activities (regular and occasional) and fixed jobs (51.8%) was very close to that of unemployed (48.2%) (Table 1).

Table 1. Sociodemographic and clinical characteristics and behavioral lifestyle of people with the human immunodeficiency virus (HIV) linked to a reference service for HIV treatment, Belo Horizonte, Minas Gerais, Brazil, 2015 (n = 208). 

Characteristics n* %
Gender (male) 162 77.8
Age (in years) (31-47) 104 50.0
Education (≤ 8 years of schooling) 92 50.5
Color (brown/black) 158 76.3
Marital status (single/widowed/separated) 147 71.4
Children (yes) 93 52.5
Place of residence (Belo Horizonte) (yes) 146 70.2
Working (yes) 98 51.8
Health service entry route (outpatient) 127 61.1
Clinics and laboratories
Viral load at the diagnosis: ≤ 100 thousand copies/mL 96 54.5
CD4+ T at HIV diagnosis
≥ 500 cells/mm3 36 20.5
201-499 cells/mm3 47 26.7
≤ 200 cells/mm3 93 52.8
CD4+ T at first consultation
≥ 500 cells/mm3 40 20.3
201-499 cells/mm3 62 29.2
≤ 200 cells/mm3 101 50.5
Clinical condition at first consultationa: no aids (Categories A/B) 117 56.2
Comorbidityb (at least one) 70 33.7
Metabolic diseasesc (at least one) 43 20.7
Coinfectiond (at least one) 141 67.8
Tuberculosis 14 6.7
Visceral Leishmaniasis 7 3.8
Others 119 57.2
STI (yes) 29 13.9
Psychiatric diagnosise (at least one) 42 20.2
Behavioral lifestyle
Use of alcohol in life (yes) 105 59.7
Use of tobacco in life (yes) 149 82.8
Use of marijuana in life (yes) 52 30.8
Use of cocaine in life (yes) 50 30.1
Use of crack in life (yes) 29 17.4
Use of other illicit drugs in lifef (yes) 21 12.5

*Total varies due to ignored data; CD4+ T: CD4+ T lymphocites; aClassification for HIV/CDC diseases (category A, category B and category C) at the first visits; bcomorbidities registered at the first visit (immunological diseases, cancer and metabolic diseases); cdiagnosis at the first consultation of diabetes, hypertension, dyslipidemia, hyperglyceridemia, hypothyroidism; dinfectious diseases recorded at the first visit and those registered at the hospital and collected from medical records; STI: sexually transmitted infections; ediagnosis of mental disorders grouped into severe and non-severe at the first visit; fecstasy, amphetamines, LSD, injectable drugs.

As for the clinical characteristics, there was great variation and dispersion between the values of the VL count in the diagnosis of HIV. This value ranged from 140 cells/mm3 to the maximum detectable limit of 10,000,000 cells/mm, with a mean ± SD = 351,000 ± 1,046,565 and a median of 81,000 copies/mL. The CD4+ T count presented mean ± SD = 284.1 ± 283.1 cells/mm3, median equal to 183.5 cells/mm3, ranging from 1 to 1,315 cells/mm3. VL and CD4+ T count values were absent for 33 patients.

Regarding the clinical condition in the first consultation, there was a predominance of patients classified in category C (43.7%), which showed that almost half were in AIDS-defining conditions. It was found that one-third of the individuals had some kind of comorbidity, such as psoriasis, arthrosis, obesity, glaucoma, ichthyosis, asthma, chronic kidney disease, cancer and metabolic disease (diabetes, hypertension, dyslipidemia, hypertriglyceridemia, hypothyroidism), among others.

Among patients with some type of comorbidity, 27.1% had two or more of them (Table 1). Regarding co-infections, more than half (67.8%) had infectious diseases at the time of service linkage. Among them, 13.9% were sexually transmitted infections (STI) and 10.6% were tuberculosis and leishmaniasis.

Among the registered mental disorders, 20.2% of the patients were diagnosed with psychosis, depression with psychotic symptoms and bipolar disorder, depression and anxiety, dementia, among others. Regarding lifestyle habits, almost 60% of patients reported at the first consultation that they currently consumed alcohol or consumed alcohol at some point in their lives, 82.8% currently smoked tobacco or smoked tobacco at some point in their lives, 43.1% used or have used at least one illicit drug, with marijuana being the most frequent one (30.8%) (Table 1).

Mostly, individuals were linked to the service within 90 days (timely care linkage) after the diagnosis of HIV.The average care linkage time was 138 days, with SD = 397.9, median equal to 37, ranging from 0 to 3,108 days. In the univariate analysis, the variables being 48 years old or older, having more than eight years of schooling, being married or living in a stable union, and having ever used cocaine during life were modeled in the multivariate analysis (p <0.20). The variables work and present CD4+ T count ≤ 200 cells/mm3 were significantly associated in the univariate analysis (p <0.05) (Table 2).

Table 2. Univariate analysis of factors associated with timely care linkage (≤ 90 days) to a referral service for treatment of human immunodeficiency virus (HIV), Belo Horizonte, Minas Gerais, 2015 (n = 208). 

Variables Timely care linkage Univariate analysis Multivariate analysis
≤ 90 days OR (95%CI) p OR (95%CI) p
n (%)
Male 36 (78.3) 0.91 (0.41 - 1.99) 0.807 --- ---
Female 124 (76.5) 1
Age (years)
≥ 48 41 (87.2) 2.67 (0.95 - 7.49) 0.063 8.50 (1.53 - 47.28) 0.014*
31-47 78 (75.0) 1.17 (0.56 - 2.43) 0.672 1.74 (0.65 - 4.62) 0.268
18-30 41 (71.9) 1
Education (years)
> 8 66 (73.3) 0.58 (0.28 - 1.18) 0.131 --- ---
≤ 8 76 (82.6) 1
White 37 (75.5) 0.91 (0.43 - 1.93) 0.805 --- ---
Black/Brown 122 (77.2) 1
Marital status
Married/Stable union 50 (84.7) 1.94 (0.87 - 4.31) 0.101 --- ---
Single/Widowed /Separated 109 (74.1) 1
Children --- ---
Yes 75 (80.6) 1.57 (0.78 - 3.17) 0.206
No 61 (72.6) 1
Place of residence
Belo Horizonte 111 (76.0) 0.84 (0.41 - 1.73) 0.638 --- ---
Does not live in Belo Horizonte 49 (79.0) 1
Yes 82 (83.7) 2.05 (1.02 - 4.14) 0.043 3.69 (1.33 - 10.25) 0.043*
No 65 (71.4) 1
Health Service
Entry route
Outpatient 99 (78.0) 1.15 (0.60 - 2.23) 0.659 --- ---
Hospitalization 61 (75.3) 1
Clinical and laboratorial
Viral load HIV diagnosis
≤ 100 thousand copies/mL 62 (77.5) 1.28(0.64-2.55) 0.484 --- ---
> 101 thousand copies /mL 70 (72.9) 1
CD4+ T HIV diagnosis
≤ 200 cells/mm3 77 (82.8) 3.01 (1.30 - 7.24) 0.011 4.84 (1.54 - 15.18) 0.007*
200-499 cells/mm3 32 (68.1) 1.36 (0.55 - 3.37) 0.510 2.53 (0.72 - 8.82) 0.148
≥ 500 cells/mm3 22 (61.1) 1
CD4+ T at first consultation
≤ 200 cells/mm3 79 (77.5) 1.25 (0.54 - 2.89) 0.587 --- ---
200-499 cells/mm3 46 (78.0) 1.29 (0.51 - 3.27) 0.581 --- ---
≥ 500 cells/mm3 30 (73.2) 1
Clinical condition at first consultation
With aids (Category C) 71 (78.0) 1.12 (0.57 - 2.30) 0.740 --- ---
No aids (Categories A/B) 89 (76.1) 1
Yes 55 (78.6) 1.15 (0.58 - 2.30) 0.688 --- ---
No 105 (76.1) 1
Metabolic diseases
Yes 34 (79.1) 1.17 (0.51 - 2.64) 0.708 --- ---
No 126 (76.4) 1
Yes 107 (75.9) 0.83 (0.41 - 1.68) 0.607 --- ---
No 53 (79.1) 1
Psychiatric diagnosis
Yes 33 (78.6) 1.09 (0.58 - 2.08) 0.777 --- ---
No 127 (76.5) 1
Life habits
Use of alcohol (in life)
Yes 79 (75.2) 0.96 (0.47 - 1.93) 0.901 --- ---
No 54 (76.1) 1
Tobacco smoking
Yes 113 (75.8) 1.09 (0.45 - 2.65) 0.846 --- ---
No 23 (74.2) 1
Use of marijuana (in life)
Yes 38 (73.1) 0.78 (0.36 - 1.64) 0.507 --- ---
No 91 (77.8) 1
Use of cocaine (in life)
Yes 35 (70.0) 0.61 (0.28 - 1.29) 0.194 --- ---
No 92 (79.3) 1’
Use of crack (in life)
Yes 20 (69.0) 0.62 (0.25 - 1.45) 0.282 --- ---
No 108 (78.3) 1
Use of other illicit drugs (in life)
Yes 16 (76.2) 1.00 (0.34 - 2.93) 1.000 --- ---
No 112 (76.2) 1

OR: odds ratio; 95% CI: 95% confidence interval; LT: lymphocytes; * multivariate analysis: Hosmer-Lemeshow test: X2 = 3.407, degree of freedom (DF) = 7, p = 0.845.

In the multivariate analysis, the variables that remained in the final model (Table 2), considering p value <0.05, were 48 years old or older (OR = 8.50; 95%CI 1.53 - 47.28); currently working (OR = 3.69; 95%CI 1.33 - 10.25) and present CD4+ T count ≤ 200 cells/mm3 at diagnosis (OR = 4.84; 95%CI 1.54 - 15.18). The Hosmer-Lemeshow test presented χ2 = 3.407, degree of freedom (DF) = 7, p = 0.845.


It was observed in this study that the average linkage time was 138 days and that delays of a few months or more between the diagnosis of HIV infection and first care may be common24. In addition, delayed linkage may be preceded by a delay between HIV infection and diagnosis, and most people are tested only after the development of AIDS symptoms25. Authors describe that delayed linkage is associated with advanced immune suppression, which leads to worse health outcomes for individuals24,25,26.

On the other hand, more than two-thirds of people joined the service 90 days or less after the diagnosis of HIV (timely care linkage), a result similar to that of high-income countries12,27,28. A study that included a meta-analysis from 1995 to 2009 found that 69% of people diagnosed with HIV in the United States were on time for treatment, and 72% were on treatment in less than four months29. In a 2011 systematic review including 10 studies conducted in sub-Saharan Africa, it was found that the average proportion of 59%9 of PLHIV had been linked to health care in two or three months. There is evidence that more timely linkage is associated to longer survival30.

However, in the present study, it was found that among the patients who were timely linked, the majority (78%) had AIDS-defining conditions (categories A3, B3, C1, C2, C3), similarly to other studies in the literature30,31,32,33, 34. That is, there was a late search for health services30,33.

In the final model, having a CD4+ T cell count ≤ 200 cells/mm3 was positively associated with timely care linkage (≤ 90 days), i.e., people with a worse immune system are linked earlier. This finding is corroborated by other studies that point out that starting health care late is previously associated with a higher CD4+ T count32,35. In addition, other researches show that self-perception of not feeling sick is associated with later linkage26,36. Also, patients with low CD4+ T counts, especially less than 100 cells/mm3, are at higher risk for polypharmacy, opportunistic infections, and other HIV-related complications31,34,37,38. Despite the benefit of ART, it is emphasized that these patients take longer to achieve good immune reconstitution than those who are linked with higher CD4+ T counts6,7 and that they are more susceptible to morbidity and risk of life.

Age was also positively associated with timely care linkage (≤ 90 days), showing that the likelihood of attachment increases with age. Similar studies have shown that adolescents and young adults (15-29 years) are less likely to be diagnosed and linked to care once diagnosed. Little knowledge and negative attitudes and beliefs about HIV infection at this age would explain the higher incidence of HIV in these individuals. Other studies also highlight the need for specific interventions aimed at young people and adolescents, such as the use of social marketing and the media (mobile and internet) to increase adherence to health care35,40,43.

Working patients were more likely to be linked to ongoing HIV care, as shown here. This result is in line with another study in which unemployed patients were more likely to lose themselves in the cascade of care, showing difficulty in being linked even before ART started33.

The diversity of factors involved in the health care of these patients makes the task of health professionals very complex and of great responsibility. Once the factors associated with non-timely or late linkage are known, it is possible to propose measures for increased linkage, adherence to consultations, treatment follow-up, and ART.

Monitoring the entire cascade of continuous care and especially the assessment of the early stages, linkage and retention are necessary, as they are important indicators of quality of care and process measures, thus serving as a monitoring tool to identify failures and opportunities for interventions44.

In 2014, the United Nations Joint Program on HIV/AIDS (UNAIDS) announced a continuous search target 90-90-90 to control the HIV epidemic, which states that by 2020 90% of PLHIV should be aware of their status, 90% should be under treatment, and 90% should have undetectable VL45. This goal is in line with the concept of cascading care, which aims to provide benefits to individuals already infected with HIV, as well as a public health perspective, since the increase in people with viral suppression reduces the transmission of the disease.

As a critical evaluation of this study, the difficulties of analyzing secondary source data (clinical records) are pointed out, as well as the fact that it is a referral hospital service (SOS), which may include selection bias, making it difficult to generalize the results. In Belo Horizonte, there are three referral services that attend 98.0% of PLHIV, two outpatient services, and one hospital, and the SOS of the referred hospital accounts for about one-third of patient care, with 29.8% of attendances to patients from municipalities of the state of Minas Gerais.


Our results reiterate the importance of ongoing and timely care for PLHIV, especially for young adults, with counseling and follow-up. A better understanding of HIV-related health-seeking behavior by the population is important for the design of more effective HIV care strategies.

It is necessary to strengthen strategic actions, such as the implementation of a rapid test for HIV, syphilis, and hepatitis in the basic units of Belo Horizonte, investment in research and discussions with SOS professionals about the need for timely care linkage, as well as monitoring of individuals in the cascade of continuous HIV care.

It is noteworthy that, respecting the limits of the study, the results obtained may contribute to the development of approaches to avoid untimely attachment not only in this SOS but in other specialized HIV care services.


The authors thank Belo Horizonte City Hall (MG), FHEMIG and all the professionals who work at Eduardo de Menezes Hospital. Additional support for the work was from the Pró-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (PRPq).


1. Assis MMA, de Jesus WLA. Acesso aos serviços de saúde: abordagens, conceitos, políticas e modelo de análise. Ciênc Saúde Coletiva 2012; 17(11): 2865-75. [ Links ]

2. Brasil. Secretaria de Estado de Saúde de Minas Gerais. Boletim Epidemiológico Mineiro HIV/Aids. Belo Horizonte: Subsecretaria de Vigilância e Proteção à Saúde/Superintendência de Vigilância Epidemiológica, Ambiental e Saúde do Trabalhador/Diretoria de Vigilância Epidemiológica Coordenação IST/AIDS e Hepatites Virais; 2016. ano 2. v. 2. [ Links ]

3. Reddy EA, Agala CB, Maro VP, Ostermann J, Pence BW, Itemba DK, et al. Test site predicts HIV care linkage and antiretroviral therapy initiation: a prospective 3.5-year cohort study of HIV-positive testers in northern Tanzania. BMC Infect Dis 2016; 16: 497. [ Links ]

4. Kumarasamy N, Patel A, Pujari S. Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to? Indian J Med Res 2011; 134(6): 787-800. [ Links ]

5. Palella FJ Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338(13): 853-60. [ Links ]

6. Lawn SD, Myer L, Bekker LG, Wood R. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis 2006; 6: 59. [ Links ]

7. McKinnon LR, Kimani M, Wachihi C, Nagelkerke NJ, Muriuki FK, Kariri A, et al. Effect of baseline HIV disease parameters on CD4 T cell recovery after antiretroviral therapy initiation in Kenyan women. PLoS One 2010; 5(7): e11434. [ Links ]

8. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapyfor HIV on survival. N Engl J Med 2009; 360: 1815-26. [ Links ]

9. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011; 8(7): e1001056. [ Links ]

10. Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa : a systematic review. J Int AIDS Soc 2012; 15(2): 17383. [ Links ]

11. Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clinical Infect Dis 2011; 52(6): 793-800. [ Links ]

12. Kilmarx PH, Mutasa-apollo T. Patching a leaky pipe: the cascade of HIV care. Curr Opin HIV AIDS 2013; 8(1): 59-64. [ Links ]

13. Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis 2013; 57(8): 1164-71. [ Links ]

14. Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther 2016; 13(: 35. [ Links ]

15. Elul B, Lahuerta M, Abacassamo F, Lamb MR, Ahoua L, McNairy ML, et al. A combination strategy for enhancing linkage to and retention in HIV care among adults newly diagnosed with HIV in Mozambique: study protocol for a site-randomized implementation science study. BMC Infect Dis 2014; 4: 549. [ Links ]

16. Zetola NM, Bernstein K, Ahrens K, Marcus JL, Philip S, Nieri G, et al. Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health 2009; 9: 17. [ Links ]

17. Brasil. Ministério da Saúde. Boletim Epidemiológico - AIDS e DST. Brasília: Secretaria de Vigilância em Saúde - Departamento de DST, Aids e Hepatites Virais, Ministério da Saúde; 2016. [ Links ]

18. Brasil. Ministério da Saúde. Adesão ao tratamento antirretroviral no Brasil: Coletânea de estudos do Projeto ATAR- Série B. Textos Básicos de Saúde. Brasília: Ministério da Saúde; 2010. [ Links ]

19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33(1): 159-74. [ Links ]

20. Mugavero MJ, Lin YH, Willig JH, Westfall AO, Ulett KB, Routman JS, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis 2009; 48(2): 248-56. [ Links ]

21. Nosyk B, Montaner JSG, Colley G, Lima VD, Chan K, Heath K, et al. The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study. Lancet Infect Dis 2014; 14(1): 40-9. [ Links ]

22. Silva D, De Boni RB, Lake JE, Cardoso SW, Ribeiro S, Moreira RI, et al. Retention in Early Care at an HIV Outpatient Clinic in Rio de Janeiro, Brazil, 2000-2013. AIDS Behav 2016; 20(5): 1039-48. [ Links ]

23. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recom Rep [Internet]. 1992 [acessado em jul. 2016]; 41(RR-17): 1-19. Disponível em: Disponível em: ]

24. Turner BJ, Cunningham WE, Duan N, Andersen RM, Shapiro MF, Bozzette SA, et al. Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus. Arch Intern Med 2000; 160(17): 2614-22. [ Links ]

25. Dalmida SG, McDougall GJ Jr., Mugoya GCT, Payne Foster P, Plyman M, Burrage J. Engagement of African Americans with rapid HIV testing and HIV care. HIV/AIDS Res Treat 2018; 2018: S38-S51. [ Links ]

26. Reed JB, Hanson D, McNaghten AD, Bertolli J, Teshale E, Gardner L, et al. HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000-2004. AIDS Patient Care STDS 2009; 23(9): 765-73. [ Links ]

27. Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med 2008; 168(11): 1181-7. [ Links ]

28. Ulett KB, Willig JH, Lin HY, Routman JS, Abroms S, Allison J, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS 2009; 23(1): 41-9. [ Links ]

29. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. Aids 2010; 24(17): 2665-78. [ Links ]

30. Tripathi A, Youmans E, Gibson JJ, Duffus WA. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses 2011; 27(7): 751-8. [ Links ]

31. Aaron E, Alvare T, Gracely EJ, Riviello R, Althoff A. Predictors of linkage to care for newly diagnosed HIV-positive adults. West J Emerg Med 2015; 16(4): 535-42. [ Links ]

32. Govindasamy D, Schaik VN, Kranzer K, Wood R, Mathews C, Bekker LG. Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. J Acquir Immune Defic Syndr 2011; 58(3): 344-52. [ Links ]

33. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, et al. Loss to Care and Death Before Antiretroviral Therapy in Durban, South Africa. J Acquir Immune Defic Syndr 2009; 51(2): 135-9. [ Links ]

34. Mukolo A, Villegas R, Aliyu M, Wallston KA. Predictors of late presentation for HIV diagnosis: a literature review and suggested way forward. AIDS Behav 2013; 17(1): 5-30. [ Links ]

35. Nakigozi G, Makumbi F, Reynolds S, Galiwango R, Kagaayi J, Nalugoda F, et al. Non-enrollment for free community HIV care: findings from a population-based study in Rakai, Uganda. AIDS Care 2011; 23(6): 764-70. [ Links ]

36. Neduzhko O, Postnov O, Perehinets I, DeHovitz J, Joseph M, Odegaard D, et al. Factors Associated with Delayed Enrollment in HIV Medical Care among HIV-Positive Individuals in Odessa Region, Ukraine. J Int Assoc Provid AIDS Care 2017; 16(2): 168-73. [ Links ]

37. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Padmanabhan L, Stein MD. Discontinuation from HIV medical care: squandering treatment opportunities. J Health Care Poor Underserved 2003; 14(2): 244-55. [ Links ]

38. Bakera JV, Peng G, Rapkin J, Abrams DI, Silverberg MJ, MacArthur RD, et al. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS (London, England) 2008; 22(7): 841-8. [ Links ]

39. Maman D, Ben-Farhat J, Chilima B, Masiku C, Salumu L, Ford N, et al. Factors associated with HIV status awareness and Linkage to Care following home-based testing in rural Malawi. Trop Med Int Health 2016; 21(11): 1442-51. [ Links ]

40. Naik R, Doherty T, Jackson D, Tabana H, Swanevelder S, Thea DM, et al. Linkage to care following a home-based HIV counselling and testing intervention in rural South Africa. J Int AIDS Soc 2015; 18: 19843. [ Links ]

41. Pollini RA, Blanco E, Crump C, Zúñiga ML. A community-based study of barriers to HIV care initiation. AIDS Patient Care STDs 2011; 25(10): 601-9. [ Links ]

42. Giordano TP, Visnegarwala F, White AC Jr., Troisi CL, Frankowski RF, Hartman C, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care 2005; 17(6): 773-83. [ Links ]

43. Hightow-Weidman LB, Smith JC, Valera E, Matthews DD, Lyons P. Keeping them in ‘‘STYLE’’: Finding, linking, and retaining young HIV-positive Black and Latino men who have sex with men in care. AIDS Patient Care STDs 2011; 25(1): 37-45. [ Links ]

44. Gourlay AJ, Pharris AM, Noori T, Supervie V, Rosinska M, van Sighem A, et al. Towards standardized definitions for monitoring the continuum of HIV care in Europe. AIDS (London, England) 2017; 31(15): 2053-8. [ Links ]

45. UNAIDS. 90-90-90 - An ambitious target to help end the AIDS epidemic. Genebra: UNAIDS; 2014. [ Links ]

Founding source: The authors thank all researchers involved in the ECOART study, as well as Minas Gerais State Research Foun­­dation (Fapemig) (APQ 03938-16) and Pro-Rectory of Research of the Federal University of Minas Gerais (PRPq) for the financial support.

Received: October 04, 2018; Accepted: November 13, 2018

Corresponding author: Maria das Graças Braga Ceccato. Departamento de Farmácia Social, Faculdade de Farmácia, Universidade Federal de Minas Gerais. Avenida Presidente Antônio Carlos, 6.627, Campus Pampulha, CEP 31270-091, Belo Horizonte, MG, Brasil. E-mail:

Conflict of interests: nothing to declare

Authors’ contribution: Romara Elizeu Amaro Perdigão: had a substantial intellectual contribution, directly in the design and elaboration of the article, and the analysis and interpretation of data. Responsible for writing the draft. She has approved the final version to be published and agrees that she is responsible for the accuracy and completeness of the entire work. Palmira de Fátima Bonolo: had a substantial intellectual contribution, directly in the drawing and elaboration of the article. She participated in the critical review of the content and approved the final version to be published. She agrees that she is responsible for the accuracy and completeness of the entire work. Micheline Rosa Silveira: had a substantial intellectual contribution, directly in the design and elaboration of the article. She participated in the critical review of the content and approved the final version to be published. She agrees that she is responsible for the accuracy and completeness of the entire work. Dirce Inês da Silva: had a substantial intellectual contribution, directly in the design and elaboration of the article. She participated in the critical review of the content and approved the final version to be published. She agrees that she is responsible for the accuracy and completeness of the entire work. Maria das Gracias Braga Ceccato: had a substantial intellectual contribution, directly in the design, analysis and interpretation of data and in the elaboration of the article. She participated in the critical review of the content and approved the final version to be published. She agrees that she is responsible for the accuracy and completeness of the entire work.

Creative Commons License Este é um artigo publicado em acesso aberto sob uma licença Creative Commons